P

Pacira BioSciences

PCRX

20.750
USD
0.09
(0.44%)
Market Open
Volume
6,524
EPS
0
Div Yield
0
P/E
13
Market Cap
815,524,405
Related Instruments
ABBV
4.380
(2.36%)
189.700 USD
AMGN
2.78
(0.84%)
335.22 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
B
BMRN
0.270
(0.32%)
84.620 USD
GILD
0.470
(0.62%)
76.510 USD
LLY
28.47
(3.54%)
832.74 USD
MRK
0.680
(0.60%)
113.800 USD
REGN
13.14
(1.22%)
1,091.19 USD
S
SGEN
0
(0%)
0.000000 USD
News

Title: Pacira BioSciences

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.